Oral and Gastrointestinal Mucositis: A Comprehensive Prevention and Management Guideline

Evidence-based guideline for prevention, assessment, and management of oral and GI mucositis in cancer patients receiving chemotherapy, radiation, and stem cell transplantation.

3 articles • Updated Mar 2026

Oral and GI Mucositis — Part 3: GI Mucositis, Radiation-Induced Mucositis, and HSCT Considerations

Chemotherapy-induced diarrhea management, irinotecan-specific protocols, immune checkpoint inhibitor colitis, head and neck radiation mucositis, pelvic radiation enteritis, chemoradiation, TBI-related mucositis, palifermin in HSCT, and engraftment syndrome.

guidelines•Mar 2026•guidelines

Oral and GI Mucositis — Part 2: Oral Mucositis Prevention and Management

Evidence-based oral mucositis prevention including cryotherapy, photobiomodulation, palifermin, and basic oral care; pain management; nutritional support; infection management; agents with evidence against use.

guidelines•Mar 2026•guidelines

Oral and GI Mucositis — Part 1: Pathobiology, Grading Scales, and Risk Factors

Five-phase pathobiology model of mucositis, comprehensive grading scales (WHO, NCI CTCAE, OMAS), treatment-related and patient-related risk factors, and pre-treatment dental assessment.

guidelines•Mar 2026•guidelines